Phase 3 Liver Cancer Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 2Phase 3
Trop2-targeted immunoPET Imaging of Solid Tumors
Liver CancerOvarian CancerCervical Cancer+11 more
RenJi Hospital400 enrolled1 locationNCT06851663
Recruiting
Phase 3
Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial
Liver CancerSurgeryLiver Metastases+2 more
Jon Unosson338 enrolled1 locationNCT05744219
Recruiting
Phase 3
Clinical Outcome and Future Liver Remnant Regenerative Response in Laparoscopic Versus Open ALPPS
Liver Cancer
The University of Hong Kong40 enrolled1 locationNCT04868149
Recruiting
Phase 2Phase 3
Interventional Software for Multi-immunotherapy of Solid Tumors
Liver CancerLung CancerSolid Tumor, Adult
Second Affiliated Hospital of Guangzhou Medical University60 enrolled1 locationNCT06478108
Recruiting
Phase 3
Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma
Liver Cancer
Second Affiliated Hospital of Guangzhou Medical University200 enrolled1 locationNCT03949231
Completed
Phase 3
Targeted thromboprophylaxis in ambulatory patients receiving anticancer therapies (TARGET-TP)
Liver CancerPancreatic CancerLung Cancer+4 more
Peter MacCallum Cancer Centre300 enrolled5 locationsACTRN12618000811202
Completed
Phase 2Phase 3
Immunonutrition in liver surgery
Patients with liver cancer requiring resection
Assoc. Prof. Lindsay Plank30 enrolled1 locationACTRN12612001151820